Boston Family Office LLC Gilead Sciences, Inc. Transaction History

Boston Family Office LLC

$1.39 Billion
Q2 2024

A detailed history of Boston Family Office LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Boston Family Office LLC holds 17,240 shares of GILD stock, worth $1.52 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

17,240

Previous 17,240 -0.0%

Holding current value

$1.52 Million

Previous $1.26 Million 6.33%

% of portfolio

0.09%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $22,803 - $26,010	-300 Reduced 1.71%	17,240 $1.33 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $10,823 - $12,331	-140 Reduced 0.79%	17,540 $1.46 Million
Q4 2022 Feb 07, 2023	SELL	$62.32 - $89.47 $143,336 - $205,781	-2,300 Reduced 11.51%	17,680 $1.52 Million
Q3 2022 Nov 08, 2022	SELL	$59.54 - $68.01 $14,885 - $17,002	-250 Reduced 1.24%	19,980 $1.23 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $11,544 - $13,002	-200 Reduced 0.98%	20,230 $1.25 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $91,224 - $114,313	-1,575 Reduced 7.16%	20,430 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $253,356 - $287,564	-3,905 Reduced 15.07%	22,005 $1.6 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $270,760 - $292,120	-4,000 Reduced 13.37%	25,910 $1.81 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $77,750 - $84,953	-1,225 Reduced 3.93%	29,910 $2.06 Million
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $116,100 - $132,470	-1,935 Reduced 5.85%	31,135 $2.05 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $248,693 - $283,374	-4,390 Reduced 11.72%	33,070 $1.93 Million
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $71,104 - $89,401	-1,145 Reduced 2.97%	37,460 $2.37 Million
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $3.14 Million - $3.65 Million	-43,398 Reduced 52.92%	38,605 $2.97 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $1.36 Million - $1.75 Million	-21,759 Reduced 20.97%	82,003 $6.13 Million
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $126,197 - $138,813	-2,048 Reduced 1.94%	103,762 $6.74 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $2,187 - $2,415	-35 Reduced 0.03%	105,810 $6.71 Million
Q2 2019 Jul 30, 2019	SELL	$61.87 - $69.38 $53,703 - $60,221	-868 Reduced 0.81%	105,845 $7.15 Million
Q1 2019 May 09, 2019	SELL	$62.53 - $70.05 $130,750 - $146,474	-2,091 Reduced 1.92%	106,713 $6.94 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $73,616 - $96,064	-1,216 Reduced 1.11%	108,804 $6.81 Million
Q3 2018 Nov 01, 2018	SELL	$71.28 - $78.92 $124,169 - $137,478	-1,742 Reduced 1.56%	110,020 $8.5 Million
Q2 2018 Jul 26, 2018	SELL	$64.88 - $75.68 $147,666 - $172,247	-2,276 Reduced 2.0%	111,762 $7.92 Million
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $33,215 - $40,492	-456 Reduced 0.4%	114,038 $8.6 Million
Q4 2017 Feb 06, 2018	SELL	$71.15 - $83.52 $6,759 - $7,934	-95 Reduced 0.08%	114,494 $8.2 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $8.26 Million - $9.79 Million	114,589	114,589 $9.28 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.

Account

Boston Family Office LLC Gilead Sciences, Inc. Transaction History